Teriparatide use in osteopenic patients undergoing single-level lumbar fusion associated with decreased 2-year revision rates [PDF]
Journal of Craniovertebral Junction and SpineContext: Low bone density is common among lumbar fusion patients and increases the risks of pseudarthrosis, hardware failure, and revision. Teriparatide improves bone mass and fusion in osteoporosis, but its benefit in osteopenia or normal bone remains ...
Mitchell K. Ng +10 more
doaj +2 more sources
A Phase 3 Multicenter, Double‐Blind Study Comparing Efficacy, Safety, Immunogenicity, and Pharmacokinetics of Alkem's Biosimilar Teriparatide Versus Reference Teriparatide in Postmenopausal Osteoporosis [PDF]
Aging MedicineObjective The primary purpose of this study was to compare the efficacy and safety of proposed biosimilar teriparatide with reference teriparatide in patients of postmenopausal osteoporosis.
Nitin Kapoor +18 more
doaj +2 more sources
Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis [PDF]
Asian Spine Journal, 2023 Study Design Retrospective cohort study. Purpose This study aimed to compare the efficacy of bisphosphonates and teriparatide in the management of osteoporotic vertebral compression fractures with regard to pain management, prevention of nonunion, and ...
Vishnu Vikraman Nair +5 more
doaj +1 more source
Frontiers in Public Health, 2022 ObjectiveWe aimed to assess the cost-effectiveness of sequential teriparatide/zoledronic acid relative to zoledronic acid monotherapy for postmenopausal osteoporotic women in China.MethodsA previously validated Markov microsimulation model was updated to
Ruxu You +7 more
doaj +1 more source
Bone Reports, 2020 Objective: Teriparatide has been increasingly utilized in the management of osteoporosis. The efficacy of low and high dose teriparatide on lumbar spine bone mineral density, vertebral fracture incidence and pain is unknown.
Shakib Akhter +7 more
doaj +1 more source
Comparison of the Efficacy of Romosozumab and Teriparatide for the Management of Osteoporotic Vertebral Compression Fractures [PDF]
Neurospine, 2023 Objective Romosozumab is increasingly employed to manage osteoporosis. However, no studies have analyzed its effects on recent osteoporotic vertebral compression fractures (OVCFs).
Danbi Park +7 more
doaj +1 more source
BMC Sports Science, Medicine and Rehabilitation, 2020 Background The aim of this study was to investigate the effect on physical performance of combining whole-body vibration exercise (WBV) with parathyroid hormone 1–34 (teriparatide) compared to teriparatide alone.
Ditte Beck Jepsen +5 more
doaj +1 more source
Effect of teriparatide on drug treatment of tuberculous spondylitis: an experimental study
Scientific Reports, 2022 Tuberculous spondylitis often develops catastrophic bone destruction with uncontrolled inflammation. Because anti-tuberculous drugs do not have a role in bone formation, a combination drug therapy with a bone anabolic agent could help in fracture ...
Subum Lee +8 more
doaj +1 more source
Orthopaedic Surgery, 2021 Objective To compare the preventive effects of teriparatide and alendronate on the progression of vertebral body collapse in postmenopausal single‐level Kümmell's disease (KD).
Peng‐guo Gou +8 more
doaj +1 more source
Enhancement of ghrelin-signaling system by Rikkunshi-To attenuates teriparatide-induced pica in rats
Journal of Pharmacological Sciences, 2018 Teriparatide is clinically used for the treatment of osteoporosis; however, nausea is often observed in patients. Its insufficient control affects the ability to continue teriparatide therapy.
Kouichi Yamamoto +3 more
doaj +1 more source